{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,23]],"date-time":"2025-08-23T15:40:06Z","timestamp":1755963606004,"version":"3.44.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,8,23]]},"DOI":"10.7759\/cureus.90817","type":"journal-article","created":{"date-parts":[[2025,8,23]],"date-time":"2025-08-23T15:04:26Z","timestamp":1755961466000},"source":"Crossref","is-referenced-by-count":0,"title":["Efficacy of High-Dose Atorvastatin Loading in Patients With ST-Elevation Myocardial Infarction (STEMI) Undergoing Percutaneous Coronary Intervention: A Systematic Review of Randomized Controlled Trials"],"prefix":"10.7759","author":[{"given":"Mansi","family":"Yadav","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Archana","family":"Dhami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Umar","family":"Ahsan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laiba","family":"Nadeem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatima","family":"Raja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad","family":"Raif","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hussnain","family":"Mushtaq","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Syed Momin","family":"Ali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shafeen Bashir","family":"Butt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikhil Deep","family":"Kolanu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000035687","article-title":"Comprehensive review of ST-segment elevation myocardial infarction: understanding pathophysiology, diagnostic strategies, and current treatment approaches","volume":"102","author":"Elendu C","year":"2023","unstructured":"Elendu C, Amaechi DC, Elendu TC, et al.. Comprehensive review of ST-segment elevation myocardial infarction: understanding pathophysiology, diagnostic strategies, and current treatment approaches. Medicine (Baltimore). 2023, 102:e35687. 10.1097\/MD.0000000000035687","journal-title":"Medicine (Baltimore)"},{"key":"ref2","article-title":"Acute ST-segment elevation myocardial infarction (STEMI)","author":"Akbar H","year":"2025","unstructured":"Akbar H, Mountfort S. Acute ST-segment elevation myocardial infarction (STEMI). StatPearls [Internet]. StatPearls Publishing, Treasure Island, FL; 2025."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics16020214","article-title":"Potential benefits and risks associated with the use of statins","volume":"16","author":"Khatiwada N","year":"2024","unstructured":"Khatiwada N, Hong Z. Potential benefits and risks associated with the use of statins. Pharmaceutics. 2024, 16:10.3390\/pharmaceutics16020214","journal-title":"Pharmaceutics"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2005.06.009","article-title":"Effects of statins on 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibition beyond low-density lipoprotein cholesterol","volume":"96","author":"Liao JK","year":"2005","unstructured":"Liao JK. Effects of statins on 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibition beyond low-density lipoprotein cholesterol. Am J Cardiol. 2005, 96:24F-33F. 10.1016\/j.amjcard.2005.06.009","journal-title":"Am J Cardiol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2009.11.021","article-title":"Efficacy of high-dose atorvastatin loading before primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: the STATIN STEMI trial","volume":"3","author":"Kim JS","year":"2010","unstructured":"Kim JS, Kim J, Choi D, et al.. Efficacy of high-dose atorvastatin loading before primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: the STATIN STEMI trial. JACC Cardiovasc Interv. 2010, 3:332-9. 10.1016\/j.jcin.2009.11.021","journal-title":"JACC Cardiovasc Interv"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2013.01.009","article-title":"Administration of a loading dose of atorvastatin before percutaneous coronary intervention prevents inflammation and reduces myocardial injury in STEMI patients: a randomized clinical study","volume":"35","author":"Liu HL","year":"2013","unstructured":"Liu HL, Yang Y, Yang SL, Luo JP, Li H, Jing LM, Shen ZQ. Administration of a loading dose of atorvastatin before percutaneous coronary intervention prevents inflammation and reduces myocardial injury in STEMI patients: a randomized clinical study. Clin Ther. 2013, 35:261-72. 10.1016\/j.clinthera.2013.01.009","journal-title":"Clin Ther"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-021-03196-9","article-title":"Efficacy of high-dose atorvastatin or rosuvastatin loading in patients with acute coronary syndrome undergoing percutaneous coronary intervention: a meta-analysis of randomized controlled trials with GRADE qualification of available evidence","volume":"78","author":"Borovac JA","year":"2022","unstructured":"Borovac JA, Leth-Olsen M, Kumric M, D'Amario D, Schwarz K, Glavas D, Bozic J. Efficacy of high-dose atorvastatin or rosuvastatin loading in patients with acute coronary syndrome undergoing percutaneous coronary intervention: a meta-analysis of randomized controlled trials with GRADE qualification of available evidence. Eur J Clin Pharmacol. 2022, 78:111-26. 10.1007\/s00228-021-03196-9","journal-title":"Eur J Clin Pharmacol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1186\/s43044-024-00481-7","article-title":"Efficacy of single high-dose statin prior to percutaneous coronary intervention in acute coronary syndrome: a systematic review and meta-analysis","volume":"76","author":"de Liyis BG","year":"2024","unstructured":"de Liyis BG, Jagannatha GN, Kosasih AM, Darma IK, Artha IM. Efficacy of single high-dose statin prior to percutaneous coronary intervention in acute coronary syndrome: a systematic review and meta-analysis. Egypt Heart J. 2024, 76:49. 10.1186\/s43044-024-00481-7","journal-title":"Egypt Heart J"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2005.06.028","article-title":"Safety of high-dose atorvastatin therapy","volume":"96","author":"Waters DD","year":"2005","unstructured":"Waters DD. Safety of high-dose atorvastatin therapy. Am J Cardiol. 2005, 96:69F-75F. 10.1016\/j.amjcard.2005.06.028","journal-title":"Am J Cardiol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page MJ","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al.. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021, 372:n71. 10.1136\/bmj.n71","journal-title":"BMJ"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.arcmed.2018.10.006","article-title":"Reduction of no reflow with a loading dose of atorvastatin before primary angioplasty in patients with acute ST myocardial infarction","volume":"49","author":"Garc\u00eda-M\u00e9ndez RC","year":"2018","unstructured":"Garc\u00eda-M\u00e9ndez RC, Almeida-Gutierrez E, Serrano-Cuevas L, et al.. Reduction of no reflow with a loading dose of atorvastatin before primary angioplasty in patients with acute ST myocardial infarction. Arch Med Res. 2018, 49:620-9. 10.1016\/j.arcmed.2018.10.006","journal-title":"Arch Med Res"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S135173","article-title":"High-dose atorvastatin versus moderate dose on early vascular protection after ST-elevation myocardial infarction","volume":"11","author":"Gavazzoni M","year":"2017","unstructured":"Gavazzoni M, Gorga E, Derosa G, Maffioli P, Metra M, Raddino R. High-dose atorvastatin versus moderate dose on early vascular protection after ST-elevation myocardial infarction. Drug Des Devel Ther. 2017, 11:3425-34. 10.2147\/DDDT.S135173","journal-title":"Drug Des Devel Ther"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2013.1432","article-title":"Effects of atorvastatin loading prior to primary percutaneous coronary intervention on endothelial function and inflammatory factors in patients with ST-segment elevation myocardial infarction","volume":"7","author":"Yong H","year":"2014","unstructured":"Yong H, Wang X, Mi L, Guo L, Gao W, Zhang Y, Cui M. Effects of atorvastatin loading prior to primary percutaneous coronary intervention on endothelial function and inflammatory factors in patients with ST-segment elevation myocardial infarction. Exp Ther Med. 2014, 7:316-22. 10.3892\/etm.2013.1432","journal-title":"Exp Ther Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2011.08.011","article-title":"Effects of atorvastatin pretreatment on infarct size in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention","volume":"162","author":"Hahn JY","year":"2011","unstructured":"Hahn JY, Kim HJ, Choi YJ, et al.. Effects of atorvastatin pretreatment on infarct size in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Am Heart J. 2011, 162:1026-33. 10.1016\/j.ahj.2011.08.011","journal-title":"Am Heart J"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1136\/openhrt-2021-001869","article-title":"High levels of interleukin-6 are associated with final infarct size and adverse clinical events in patients with STEMI","volume":"8","author":"T\u00f8llefsen IM","year":"2021","unstructured":"T\u00f8llefsen IM, Shetelig C, Seljeflot I, Eritsland J, Hoffmann P, Andersen G\u00d8. High levels of interleukin-6 are associated with final infarct size and adverse clinical events in patients with STEMI. Open Heart. 2021, 8:10.1136\/openhrt-2021-001869","journal-title":"Open Heart"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/392709-efficacy-of-high-dose-atorvastatin-loading-in-patients-with-st-elevation-myocardial-infarction-stemi-undergoing-percutaneous-coronary-intervention-a-systematic-review-of-randomized-controlled-trials","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,23]],"date-time":"2025-08-23T15:04:27Z","timestamp":1755961467000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/392709-efficacy-of-high-dose-atorvastatin-loading-in-patients-with-st-elevation-myocardial-infarction-stemi-undergoing-percutaneous-coronary-intervention-a-systematic-review-of-randomized-controlled-trials"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,23]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.90817","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8,23]]}}}